Drägerwerk AG & Co. KGaA (DGWPF) Stock Price, News & Analysis

Company Overview

Drägerwerk AG & Co. KGaA (OTCMKTS: DGWPF) is a Germany-based technology company specializing in medical and safety solutions. Founded in 1889 and headquartered in Lübeck, Dräger serves hospitals, emergency responders, and industrial clients around the globe.

In its medical division, Dräger offers a comprehensive range of products for acute care environments. The portfolio includes ventilators, anesthesia machines, patient monitoring systems, infusion pumps, and neonatal care equipment. These solutions are designed to enhance clinical workflows, ensure patient safety, and provide seamless data integration across operating rooms, intensive care units, and patient transport settings.

Dräger’s safety technology segment develops equipment to protect against respiratory and gas hazards. Key offerings include self-contained breathing apparatus for firefighters, industrial and fixed gas detection systems, personal protective gear, and confined-space safety solutions. These products support first responders, industrial personnel, and military users in managing chemical, biological, and respiratory risks.

With production facilities in Europe, the Americas, and the Asia-Pacific region, Dräger maintains a presence in more than 190 countries through its sales and service network. The company continues to invest in research and development, focusing on digital connectivity, artificial intelligence, and data-driven applications to advance its leadership in both healthcare and safety technology markets.

Key Stats

• Today's Range: $65.39 to $65.39
• 50-Day Range: $57.00 to $65.39
• 52-Week Range: $55.81 to $65.39
• Volume: 100 shs
• Average Volume: 125 shs
• Market Capitalization: N/A
• P/E Ratio: 11.87
• Dividend Yield: 1.06%
• Price Target: N/A
• Consensus Rating: N/A

Drägerwerk AG & Co. KGaA Stock Analysis - MarketRank™

Drägerwerk AG & Co. KGaA scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Drägerwerk AG & Co. KGaA.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Drägerwerk AG & Co. KGaA is 11.87, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 231.21.

Price to Earnings Ratio vs. Sector

The P/E ratio of Drägerwerk AG & Co. KGaA is 11.87, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 84.63.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Drägerwerk AG & Co. KGaA has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Drägerwerk AG & Co. KGaA pays a meaningful dividend of 1.06%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Drägerwerk AG & Co. KGaA does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Drägerwerk AG & Co. KGaA has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Drägerwerk AG & Co. KGaA this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Drägerwerk AG & Co. KGaA insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 13.86% of the stock of Drägerwerk AG & Co. KGaA is held by institutions.

DGWPF Stock Analysis - Frequently Asked Questions

How have DGWPF shares performed this year?

Drägerwerk AG & Co. KGaA's stock was trading at $45.05 at the beginning of 2025. Since then, DGWPF shares have increased by 45.1% and is now trading at $65.39.

How do I buy shares of Drägerwerk AG & Co. KGaA?

Shares of DGWPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/17/2025
• Next Earnings (Estimated): 10/29/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:DGWPF
• CIK: N/A
• Web: www.draeger.com
• Phone: 494518820
• Fax: N/A
• Employees: 16,476
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 11.87
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A